Amgen Conference Call to Discuss New Topline Data in Inflammation and Rare Disease Tuesday, 09.24.2024 1:30 PM PDT Click here for webcast Supporting Materials Rocatinlimab and UPLIZNA Investor Update Presentation 838.2 KB
